"Fraudsters!" - Prescription drug giant convicted of fraud

United States — GlaxoSmithKline (GSK) is expected to pay $3bn (£1.9bn) in the largest healthcare fraud settlement in the history of the US.  


It is reported that the drug giant GSK is to plead guilty in the charges laid against them.  


It is said that GSK is guilty of promoting two drugs for unapproved uses and not reporting the safety data of using a diabetes drug to the Food and Drug Administration (FDA) also known as off-label marketing.  


The case concerns the drugs Paxil, Wellbutrin and Avandia.  


GSK is also said to be guilty of bribing doctors.  

According to GSK's chief executive,  Andrew Witty,  procedures for compliance, marketing and selling had been changed at GSK's United States unit.

"We have learnt from the mistakes that were made," Mr Witty said. "When necessary, we have removed employees who have engaged in misconduct."